冠状动脉扩张症的发病机制及抗栓治疗临床研究  

Clinical research in the pathogenesis and antithrombotic therapy of coronary artery ectasia

作　　者：张配涓 陈美润 王思梦 宗义君 Zhang Peijuan;Chen Meirun;Wang Simeng;Zong Yijun(School of Nursing,Hebei University of Traditional Chinese Medicine,Shijiazhuang 050000,China)

机构地区：[1]河北中医学院护理学院,石家庄050000

出　　处：《心脑血管病防治》2023年第8期36-39,共4页CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT

摘　　要：冠状动脉扩张症是一种罕见的心血管疾病,该病在接受冠状动脉造影的人群中发病率为1.2%~9.9%。目前其确切的发病机制尚未完全明确,研究发现其主要病因可能是动脉粥样硬化。该病的治疗处于探索阶段,缺乏最佳治疗方案,现总结目前文献对冠状动脉扩张症病因学、抗栓药物治疗方法以及抗栓药物治疗护理上的最新研究进展。Coronary artery ectasia is a rare cardiovascular phenotypic disease,with an incidence of 1.2%to 9.9%in patients undergoing coronary angiography.At present,the exact pathogenesis of the disease has not been fully clarified,but studies have found that the main cause of the disease may be atherosclerosis.The treatment of this disease is still in the exploratory stage,and there is no optimal treatment plan.This paper summarizes the latest research progress of etiology,antithrombotic drug therapy and nursing of antithrombotic drug therapy of coronary artery ectasia in current literature.

关 键 词：冠状动脉扩张症 冠状动脉粥样硬化 抗栓治疗 护理 

分 类 号：R473.5[医药卫生—护理学]